FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912223640> ?p ?o ?g. }

• W2912223640 endingPage "S418" @default.
• W2912223640 startingPage "S418" @default.
• W2912223640 abstract "5-ASA remains the mainstay of therapy in mild-to-moderate ulcerative colitis (UC) enabling achievement of remission in between 50–75% of all patients. Combination of immunosuppressives (IS) has been found to be associated with a better outcome when compared with monotherapy. However, concerning 5-ASA combination with biologics, clinical practice is highly variable and the evidence on potential benefit is scarce. We aimed to evaluate the course of UC in patients being treated with a combination of 5-ASA and biologics vs. biologics alone. We analysed the prospectively collected clinical data from all UC patients currently receiving biologic treatment and participating in the nation-wide Swiss IBD cohort study (SIBDCS) with vs. without 5-ASA co-treatment. At last clinical follow-up visit amongst the 366 identified UC patients with currently ongoing biologic treatment, 170 received 5-ASA co-treatment. Regarding key baseline characteristics, including sex, duration of disease and age at UC diagnosis, there were no differences between patients with vs. without 5-ASA. More patients with 5-ASA co-treatment were under concomitant therapy with IS and/or steroids. Moreover, disease activity in the 5-ASA combination group was significantly higher. No differences across groups were identified considering most recent, maximal and average levels of faecal calprotectin and leucocyte count, CRP and haemoglobin from blood samples. The occurrence of complications, for example, cancer, dysplasia, anaemia, osteoporosis, thromboembolism or extraintestinal manifestations (EIM) was similar. However, combination lead to less intestinal surgery. Population characteristics Population characteristics Events Events In our cohort, we found that UC patients under biologic therapy receiving 5-ASA co-treatment had a similar risk of complications or EIM while having a lower risk of colonic surgery. This being despite the fact that 5-ASA co-treated patients appear to reflect a subgroup of UC patients with a more severe course of disease as suggested by disease activity and co-treatment with IS and steroids. As no randomised prospective studies investigating this issue can be expected, further long-term observations in cohort studies and registries are mandatory to investigate the place of concomitant 5-ASA in UC patients receiving ‘advanced’ treatments." @default.
• W2912223640 created "2019-02-21" @default.
• W2912223640 creator A5027832292 @default.
• W2912223640 creator A5034073531 @default.
• W2912223640 creator A5044465546 @default.
• W2912223640 creator A5054681942 @default.
• W2912223640 creator A5058012401 @default.
• W2912223640 creator A5058227847 @default.
• W2912223640 creator A5079584406 @default.
• W2912223640 date "2019-01-25" @default.
• W2912223640 modified "2023-09-27" @default.
• W2912223640 title "P604 Biologics with or without a combination with 5-ASA in ulcerative colitis: frequency of usage and effect on the course of disease in the Swiss IBD-Cohort study" @default.
• W2912223640 doi "https://doi.org/10.1093/ecco-jcc/jjy222.728" @default.
• W2912223640 hasPublicationYear "2019" @default.
• W2912223640 type Work @default.
• W2912223640 sameAs 2912223640 @default.
• W2912223640 citedByCount "2" @default.
• W2912223640 countsByYear W29122236402019 @default.
• W2912223640 countsByYear W29122236402023 @default.
• W2912223640 crossrefType "journal-article" @default.
• W2912223640 hasAuthorship W2912223640A5027832292 @default.
• W2912223640 hasAuthorship W2912223640A5034073531 @default.
• W2912223640 hasAuthorship W2912223640A5044465546 @default.
• W2912223640 hasAuthorship W2912223640A5054681942 @default.
• W2912223640 hasAuthorship W2912223640A5058012401 @default.
• W2912223640 hasAuthorship W2912223640A5058227847 @default.
• W2912223640 hasAuthorship W2912223640A5079584406 @default.
• W2912223640 hasConcept C126322002 @default.
• W2912223640 hasConcept C201903717 @default.
• W2912223640 hasConcept C2776999253 @default.
• W2912223640 hasConcept C2778260677 @default.
• W2912223640 hasConcept C2778292693 @default.
• W2912223640 hasConcept C2778715236 @default.
• W2912223640 hasConcept C2779134260 @default.
• W2912223640 hasConcept C2779384505 @default.
• W2912223640 hasConcept C2780479503 @default.
• W2912223640 hasConcept C2908647359 @default.
• W2912223640 hasConcept C71924100 @default.
• W2912223640 hasConcept C72563966 @default.
• W2912223640 hasConcept C99454951 @default.
• W2912223640 hasConceptScore W2912223640C126322002 @default.
• W2912223640 hasConceptScore W2912223640C201903717 @default.
• W2912223640 hasConceptScore W2912223640C2776999253 @default.
• W2912223640 hasConceptScore W2912223640C2778260677 @default.
• W2912223640 hasConceptScore W2912223640C2778292693 @default.
• W2912223640 hasConceptScore W2912223640C2778715236 @default.
• W2912223640 hasConceptScore W2912223640C2779134260 @default.
• W2912223640 hasConceptScore W2912223640C2779384505 @default.
• W2912223640 hasConceptScore W2912223640C2780479503 @default.
• W2912223640 hasConceptScore W2912223640C2908647359 @default.
• W2912223640 hasConceptScore W2912223640C71924100 @default.
• W2912223640 hasConceptScore W2912223640C72563966 @default.
• W2912223640 hasConceptScore W2912223640C99454951 @default.
• W2912223640 hasIssue "Supplement_1" @default.
• W2912223640 hasLocation W29122236401 @default.
• W2912223640 hasOpenAccess W2912223640 @default.
• W2912223640 hasPrimaryLocation W29122236401 @default.
• W2912223640 hasRelatedWork W2044341494 @default.
• W2912223640 hasRelatedWork W2070285775 @default.
• W2912223640 hasRelatedWork W2124908533 @default.
• W2912223640 hasRelatedWork W2258300052 @default.
• W2912223640 hasRelatedWork W2408939568 @default.
• W2912223640 hasRelatedWork W2409879998 @default.
• W2912223640 hasRelatedWork W2412773332 @default.
• W2912223640 hasRelatedWork W2418837291 @default.
• W2912223640 hasRelatedWork W2512626908 @default.
• W2912223640 hasRelatedWork W4250621656 @default.
• W2912223640 hasVolume "13" @default.
• W2912223640 isParatext "false" @default.
• W2912223640 isRetracted "false" @default.
• W2912223640 magId "2912223640" @default.
• W2912223640 workType "article" @default.